Several in silico analyses have correlated p53 inactivation with immunosuppressed tumor phenotypes and decreased immune cell infiltration [83,84,85], but only recently has the role for mutant p53 in the suppression of cGAS–STING–TBK–IRF3 signaling been demonstrated [34]. This evidence concerns the gene TP53 and neoplasm.